Literature DB >> 34024143

Inflammatory response and matrix metalloproteinases in chronic kidney failure: Modulation by adropin and spexin.

Burak Yazgan1,2, Filiz Avcı2, Gülsün Memi3,4, Ebru Tastekin5.   

Abstract

Chronic kidney disease is a major global public health problem. The peptide hormones adropin and spexin modulate many physiological functions such as energy balance and glucose, lipid and protein metabolism. However, it is unclear whether these peptides may exert effects on renal damage, tissue remodeling, and inflammatory conditions. In view of the limited information, we aimed to investigate the effect of adropin and spexin on matrix metalloproteinase and inflammatory response genes a rat model of adenine-induced chronic kidney failure. Chronic kidney failure was induced in rats by administering adenine hemisulfate. Renal function was determined in an autoanalyzer. Histopathological modifications were assessed by H&E staining. mRNA expression levels of ALOX 15, COX 1, COX 2, IL-1β, IL-10, IL-17A, IL-18 IL-21, IL-33, KIM-1, MMP-1, MMP-2, MMP-3, MMP-7, MMP-9, MMP-13, NGAL, TGFβ1, TIMP-1, and TNFα in kidney tissue were measured by qPCR. Our results showed an increase of 24-h urine volume, serum creatinine, BUN, and urine protein levels in group with adenine-induced CKF. Adropin and spexin treatments decreased urine protein and 24-h urine volume. Renal damage, TIMP-1, IL-33, and MMP-2 increased after CKF induction, while COX 1, MMP-9, and MMP-13 levels were significantly reduced. Furthermore, KIM-1, TIMP-1, IL-33, and MMP-2 were downregulated by spexin treatment. Renal damage, NGAL, TIMP-1 IL-17A, IL-33, MMP-2, and MMP-3 decreased after adropin treatment, while MMP-13 levels were upregulated. Treatment with adropin+spexin decreased KIM-1, NGAL, TIMP-1, IL-1β, IL-17A, IL-18, IL-33, ALOX 15, COX 1, COX 2, TGFβ1, TNFα, MMP-2, MMP-3, and MMP-7, but increased MMP-13 levels. Our findings revealed that inflammatory response and MMP genes were modulated by adropin and spexin. These peptides may have protective effects on inflammation and chronic kidney damage progression.

Entities:  

Keywords:  Chronic kidney failure; adropin; inflammation; matrix metalloproteinase; spexin

Mesh:

Substances:

Year:  2021        PMID: 34024143      PMCID: PMC8424640          DOI: 10.1177/15353702211012417

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  62 in total

Review 1.  IL-33/ST2 Axis in Organ Fibrosis.

Authors:  Ourania S Kotsiou; Konstantinos I Gourgoulianis; Sotirios G Zarogiannis
Journal:  Front Immunol       Date:  2018-10-24       Impact factor: 7.561

Review 2.  Matrix Metalloproteinases in Kidney Disease: Role in Pathogenesis and Potential as a Therapeutic Target.

Authors:  Alan R Parrish
Journal:  Prog Mol Biol Transl Sci       Date:  2017-05-04       Impact factor: 3.622

3.  Serum levels of IL-6, IL-8 and IL-10 and risks of end-stage kidney disease and mortality.

Authors:  Teresa K Chen; Michelle M Estrella; Lawrence J Appel; Josef Coresh; Shengyuan Luo; Wassim Obeid; Chirag R Parikh; Morgan E Grams
Journal:  Nephrol Dial Transplant       Date:  2021-02-20       Impact factor: 5.992

4.  Adropin regulates cardiac energy metabolism and improves cardiac function and efficiency.

Authors:  Tariq R Altamimi; Su Gao; Qutuba G Karwi; Arata Fukushima; Sonia Rawat; Cory S Wagg; Liyan Zhang; Gary D Lopaschuk
Journal:  Metabolism       Date:  2019-06-14       Impact factor: 8.694

Review 5.  Adenine-induced chronic kidney disease in rats.

Authors:  Vishal Diwan; Lindsay Brown; Glenda C Gobe
Journal:  Nephrology (Carlton)       Date:  2018-01       Impact factor: 2.506

6.  Elevated plasma levels of adropin in heart failure patients.

Authors:  Wenlin Lian; Xiaosong Gu; Yongwen Qin; Xing Zheng
Journal:  Intern Med       Date:  2011-08-01       Impact factor: 1.271

Review 7.  IL‑33 and kidney disease (Review).

Authors:  Feifei Yang; Ping Zhu; Lihua Duan; Lin Yang; Jiajun Wang
Journal:  Mol Med Rep       Date:  2015-11-06       Impact factor: 2.952

8.  Spexin is a novel human peptide that reduces adipocyte uptake of long chain fatty acids and causes weight loss in rodents with diet-induced obesity.

Authors:  José L Walewski; Fengxia Ge; Harrison Lobdell; Nancy Levin; Gary J Schwartz; Joseph R Vasselli; Afons Pomp; Gregory Dakin; Paul D Berk
Journal:  Obesity (Silver Spring)       Date:  2014-03-08       Impact factor: 5.002

9.  Association of Serum Adropin Concentrations with Diabetic Nephropathy.

Authors:  Wenchao Hu; Li Chen
Journal:  Mediators Inflamm       Date:  2016-07-28       Impact factor: 4.711

Review 10.  A Review of Adropin as the Medium of Dialogue between Energy Regulation and Immune Regulation.

Authors:  Shuyu Zhang; Qingquan Chen; Xuchen Lin; Min Chen; Qicai Liu
Journal:  Oxid Med Cell Longev       Date:  2020-03-04       Impact factor: 6.543

View more
  3 in total

Review 1.  Impact of spexin on metabolic diseases and inflammation: An updated minireview.

Authors:  İbrahim Türkel; Gülsün Memi; Burak Yazgan
Journal:  Exp Biol Med (Maywood)       Date:  2022-01-22

Review 2.  Matrix Metalloproteinase-10 in Kidney Injury Repair and Disease.

Authors:  Xiaoli Sun; Youhua Liu
Journal:  Int J Mol Sci       Date:  2022-02-15       Impact factor: 5.923

3.  Effect of Fushengong Decoction on PTEN/PI3K/AKT/NF-κB Pathway in Rats With Chronic Renal Failure via Dual-Dimension Network Pharmacology Strategy.

Authors:  Hongyu Luo; Munan Wang; Ke Xu; Qiyao Peng; Bo Zou; Shi Yin; Chao Yu; Lingyan Ren; Ping Li; Li Tang; Yongbo Peng; Xuekuan Huang
Journal:  Front Pharmacol       Date:  2022-03-15       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.